{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:46:14Z","timestamp":1778564774263,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.ijantimicag.2003.07.019","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T10:17:53Z","timestamp":1076408273000},"page":"286-290","source":"Crossref","is-referenced-by-count":61,"title":["Antiparasitic activity of risedronate in a murine model of acute Chagas\u2019 disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Luciana R","family":"Garzoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C","family":"Waghabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos M","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange L","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Nazareth L","family":"Meirelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constan\u00e7a C","family":"Britto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Docampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio A","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB1","unstructured":"World Health Organization. Control of Chagas\u2019 disease. Technical reports series 2002;905:1\u2013109."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB2","unstructured":"Pinto Dias JC, Epidemiologia. In: Brener Z, Andrade Z, Barral-Netto C, editors. Trypanosoma cruzi e doen\u00e7a de Chagas. 2nd ed. Guanabara Koogan: Rio de Janeiro; 1999. p. 48\u201374."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00001432-200112000-00012","article-title":"Specific treatment of Chagas\u2019 disease: current status and new developments","volume":"14","author":"Urbina","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1381612023396177","article-title":"Chemotherapy of Chagas\u2019 disease","volume":"8","author":"Urbina","year":"2002","journal-title":"Curr. Pharmaceut. Design"},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/1381612013397546","article-title":"Recent developments in the chemotherapy of Chagas\u2019 disease","volume":"7","author":"Docampo","year":"2001","journal-title":"Curr. Pharmaceut. Design"},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Coura","year":"2002","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB7","doi-asserted-by":"crossref","first-page":"33609","DOI":"10.1074\/jbc.274.47.33609","article-title":"Trypanosoma cruzi contains major pyrophosphate stores and its growth in vitro and in vivo is blocked by pyrophosphate analogs","volume":"274","author":"Urbina","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0169-4758(99)01531-8","article-title":"Acidocalcisome: a novel Ca2+ storage compartment in Trypanosomatids and Apicomplexan parasites","volume":"15","author":"Docampo","year":"1999","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-6851(01)00246-8","article-title":"The acidocalcisome","volume":"33","author":"Docampo","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB10","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm0002578","article-title":"Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii and Plasmodium falciparum: a potential route to chemotherapy","volume":"44","author":"Martin","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB12","doi-asserted-by":"crossref","first-page":"33930","DOI":"10.1074\/jbc.M103950200","article-title":"Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase","volume":"276","author":"Montalvetti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2003.07.020","article-title":"Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi","volume":"23","author":"Garzoni","year":"2004","journal-title":"Int. J. Antimicrob. Ag."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/AAC.46.3.929-931.2002","article-title":"In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii","volume":"46","author":"Yardley","year":"2002","journal-title":"Antimicrob. Ag. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1086\/341074","article-title":"Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate","volume":"86","author":"Rodriguez","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568005013343191","article-title":"Bisphosphonates as chemotherapeutic agents against Trypanosomatid and Apicomplexan parasites","volume":"1","author":"Docampo","year":"2001","journal-title":"Curr. Drug Targets: Infect. Disord."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1359\/jbmr.2000.15.5.971","article-title":"The intracellular target of the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase","volume":"15","author":"Grove","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1999.1502","article-title":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase","volume":"373","author":"Bergstrom","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.59.2.193","article-title":"Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation","volume":"59","author":"Reszka","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB20","first-page":"235","article-title":"Structure\u2013activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB21","first-page":"191","article-title":"Sobre uma cepa de Trypanosoma cruzi virulenta para o camundongo branco","volume":"20","author":"Silva","year":"1953","journal-title":"Folia Clin. Biol."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0035-9203(83)90176-1","article-title":"Suggested guidelines for work with live Trypanosoma cruzi","volume":"77","author":"Hudson","year":"1983","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1126\/science.273.5277.969","article-title":"Cure of short- and long-term experimental Chagas\u2019 disease using D0870","volume":"273","author":"Urbina","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.42.7.1771","article-title":"Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies","volume":"42","author":"Urbina","year":"1998","journal-title":"Antimicrob. Ag. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.07.019_BIB25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4269\/ajtmh.1994.51.771","article-title":"Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area","volume":"51","author":"Wincker","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T17:21:15Z","timestamp":1585588875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903004072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0924857903004072"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.07.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}